Rigel Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	113.3	17.49	-25.09	-58.57	-17.91	-29.74
Depreciation & Amortization	2.42	2.23	1.24	1	1.16	0.71
Loss (Gain) From Sale of Assets	-0.06	-0.08	0.27	-0.14	-	-
Loss (Gain) From Sale of Investments	-1.18	-0.71	-0.48	-0.06	0.29	-0.12
Stock-Based Compensation	12.05	12.39	8.81	12.39	9.49	7.3
Other Operating Activities	-39.98	-	-	0.68	3.14	-
Change in Accounts Receivable	-15.35	-11.07	9.77	-24.85	0.5	-5.86
Change in Inventory	-4.84	0.76	1.17	-2.38	-4.88	-0.13
Change in Accounts Payable	0.03	-3.8	-0.37	3.79	0.04	-0.33
Change in Unearned Revenue	-	-	-0.01	-1.23	-0.42	-23.63
Change in Other Net Operating Assets	1.79	14.26	-1.05	-4.39	14.47	-0.37
Operating Cash Flow	68.18	31.47	-5.74	-73.76	5.88	-52.19
Capital Expenditures	-0.04	-0.04	-	-0.45	-0.63	-1.26
Sale of Property, Plant & Equipment	0.07	0.1	0.26	0.89	-	-
Sale (Purchase) of Intangibles	-	-0.36	-15	-	-	-
Investment in Securities	-77.95	4.43	10.44	72.33	-79.41	48.73
Investing Cash Flow	-77.92	4.13	-4.3	72.78	-80.04	47.47
Long-Term Debt Issued	-	-	19.95	19.54	-	9.98
Net Debt Issued (Repaid)	-	-	19.95	19.54	-	9.98
Issuance of Common Stock	6.64	1.96	1.05	2.12	62.68	2.6
Other Financing Activities	-	-13.61	-2.63	-15.12	-	-
Financing Cash Flow	6.64	-11.64	18.37	6.55	62.68	12.57
Net Cash Flow	-3.1	23.96	8.33	5.57	-11.48	7.85
Free Cash Flow	68.14	31.44	-5.74	-74.21	5.25	-53.45
Free Cash Flow Margin	24.16%	17.53%	-4.96%	-64.11%	3.79%	-49.20%
Free Cash Flow Per Share	3.73	1.78	-0.33	-4.35	0.31	-3.17
Cash Interest Paid	6.76	7.04	5.85	2.5	1.5	1.18
Cash Income Tax Paid	0.33	0.33	-	-	-	-
Levered Free Cash Flow	61.81	22.99	-25.76	-39.83	10.44	-41.66
Unlevered Free Cash Flow	66.54	27.93	-21.46	-37.52	13.47	-40.82
Change in Working Capital	-18.37	0.15	9.52	-29.05	9.72	-30.32

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q